Endothelial insulin receptor expression in human atherosclerotic plaques: Linking micro- and macrovascular disease in diabetes?

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 208-215

  Rensing, K L ^a   von der Thusen J H ^a,b   Weijers, E M ^c   Houttuijn Bloemendaal, F M ^a   van Lammeren, G W ^d   Vink, A ^d   van der Wal, A C ^a   van Hinsbergh, V W M ^c   van der Loos, C M ^a   Stroes, E S ^a   Koolwijk, P ^c   Twickler, Th B ^a,e  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Angiogenesis; Atherosclerosis; Diabetes mellitus type 2; Insulin; Microvessels

Indexed keywords

ANTIHYPERTENSIVE AGENT; COLLAGEN TYPE 4; INSULIN; INSULIN RECEPTOR; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CAPILLARY DENSITY; CAPILLARY TUBE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DISEASE DURATION; FAMILY HISTORY; FEMALE; FIBRIN FORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSULIN TREATMENT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MICROVASCULAR ENDOTHELIAL CELL; NEOVASCULARIZATION (PATHOLOGY); NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOKING; TREATMENT DURATION;

CELLS, CULTURED; ENDARTERECTOMY, CAROTID; ENDOTHELIUM, VASCULAR; HUMANS; INSULIN; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; RECEPTOR, INSULIN;

EID: 84859844406     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.035     Document Type: Article

References (31)

1. Mellbin L.G., Malmberg K., Norhammar A., Wedel H., Ryden L. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Eur Heart J 2008, 29:166-176.
2. Margolis D.J., Hoffstad O., Strom B.L. Association between serious ischemic cardiac outcomes and medications used to treat diabetes. Pharmacoepidemiol Drug Saf 2008, 17:753-759.
3. Currie C.J., Peters J.R., Tynan A., et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010, 375:481-489.
4. Colayco D.C., Niu F., McCombs J.S., Cheetham T.C. A1C and cardiovascular outcomes in type 2 diabetes: a nested case-control study. Diabetes Care 2011, 34:77-83.
5. Gamble J.M., Simpson S.H., Eurich D.T., Majumdar S.R., Johnson J.A. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab 2010, 12:47-53.
6. Madonna R., De Caterina R. Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling. Thromb Haemost 2009, 101:345-350.
7. Okouchi M., Okayama N., Imai S., et al. High insulin enhances neutrophil transendothelial migration through increasing surface expression of platelet endothelial cell adhesion molecule-1 via activation of mitogen activated protein kinase. Diabetologia 2002, 45:1449-1456.
8. Pfeifle B., Ditschuneit H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 1981, 20:155-158.
9. Stout R.W., Bierman E.L., Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975, 36:319-327.
10. Iida K.T., Shimano H., Kawakami Y., et al. Insulin up-regulates tumor necrosis factor-alpha production in macrophages through an extracellular-regulated kinase-dependent pathway. J Biol Chem 2001, 276:32531-32537.
11. Sluimer J.C., Daemen M.J. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 2009, 218:7-29.
12. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005, 25:2054-2061.
13. Sluimer J.C., Kolodgie F.D., Bijnens A.P., et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 2009, 53:1517-1527.
14. Henricsson M., Janzon L., Groop L. Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM. Diabetes Care 1995, 18:1571-1576.
15. Yamagishi S., Kawakami T., Fujimori H., et al. Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Microvasc Res 1999, 57:329-339.
16. Rensing K.L., Houttuijn Bloemendaal F.M., Weijers E.M., et al. Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?. Diabetologia 2010, 53:966-970.
17. van Hinsbergh V., Sprengers E.D., Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost 1987, 57:148-153.
18. Koolwijk P., van Erck M.G., de Vree W.J., et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix Role of urokinase activity. J Cell Biol 1996, 132:1177-1188.
19. Van der Loos C.M., Teeling P. A generally applicable sequential alkaline phosphatase immunohistochemical double staining. J Histotechnol 2008, 31:119-127.
20. Sternberger L.A., Joseph S.A. The unlabeled antibody method. Contrasting color staining of paired pituitary hormones without antibody removal. J Histochem Cytochem 1979, 27:1424-1429.
21. Van der Loos C.M. Immunoenzyme multiple staining methods. Royal Microscopical Society handbook no. 45 1999, BIOS Scientific publishers, Oxford, UK, p. 11-2.
22. van der Loos C.M. Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging. J Histochem Cytochem 2008, 56:313-328.
23. Verhoeven B.A., Velema E., Schoneveld A.H., et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol 2004, 19:1127-1133.
24. Hellings W.E., Pasterkamp G., Vollebregt A., et al. Intraobserver and interobserver variability and spatial differences in histologic examination of carotid endarterectomy specimens. J Vasc Surg 2007, 46:1147-1154.
25. Post S., Peeters W., Busser E., et al. Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J Vasc Res 2008, 45:244-250.
26. Kondo T., Vicent D., Suzuma K., et al. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 2003, 111:1835-1842.
27. Liu Y., Petreaca M., Martins-Green M. Cell and molecular mechanisms of insulin-induced angiogenesis. J Cell Mol Med 2008, 12:1-13.
28. Cursiefen C., Bock F., Horn F.K., et al. GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization interim results of a randomized phase II trial. Ophthalmology 2009, 116:1630-1637.
29. Li G., Barrett E.J., Wang H., Chai W., Liu Z. Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. Endocrinology 2005, 146:4690-4696.
30. Hellings W.E., Peeters W., Moll F.L., et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010, 121:1941-1950.
31. Moreno P.R., Purushothaman K.R., Sirol M., Levy A.P., Fuster V. Neovascularization in human atherosclerosis. Circulation 2006, 113:2245-2252.